Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Levitude
- Development stage
- Unknown
- Lead developer
- Ati Pharmed
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Levitude is a combined oral contraceptive (COCP) developed and manufactured by Ati Pharmed. It is a monophasic formulation containing a combination of the synthetic estrogen ethinyl estradiol (0.03 mg) and the synthetic progestin levonorgestrel (0.15 mg). Levitude primarily works by suppressing the secretion of gonadotropins (luteinizing hormone and follicle-stimulating hormone), thereby inhibiting ovulation. Additionally, it alters the cervical mucus to prevent sperm penetration and modifies the endometrium to reduce the likelihood of implantation. Beyond its primary indication for the prevention of pregnancy, Levitude is also utilized to regulate menstrual cycles, manage dysmenorrhea, and reduce the risk of ovarian cysts.
- Brand names
- AfirmelleAlesseAltaveraAmethiaAmethia LoAmethystAshlynaAubraAubra EQAvianeAyunaBalcoltraCamreseCamrese LoCerintaChatealChateal EQDayseeDelylaDolishaleElifemmeEnpresseFalminaFayosimIcleviaIntrovaleJaimiessJolessaJoyeauxKurveloLessinaLevitudeLevlenLevliteLevonestLevoraLillowLoSeasoniqueLuteraLybrelMarlissaMicrogynonMin-OvralMinzoyaMyzilraNordetteOrsythiaPortiaQuartetteQuasenseSeasonaleSeasoniqueSetlakinSimpesseSronyxSyleviaTri-LevlenTriphasilTrivoraTyblumeVienva
- Other names
- ethinyl estradiol + levonorgestrelethinyl estradiol/levonorgestrelethinylestradiol + levonorgestrelethinylestradiol/levonorgestrellevonorgestrel + ethinyl estradiollevonorgestrel and ethinyl estradiollevonorgestrel/ethinyl estradiol
02
Targets
PR (Progesterone receptor)ESR2 (ERβ)ESR1 (ERα)
Beyond the preview
Go deeper on Levitude.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Levitude.